Jackson Creek Investment Advisors’s Royalty Pharma RPRX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$745K	Buy	+12,743	New	+$663K	0.25%	176
2023 Q3	–	Sell	-13,359	Closed	-$411K	–	350
2023 Q2	$411K	Sell	13,359 -8,976	-40%	-$304K	0.16%	257
2023 Q1	$805K	Buy	22,335 +5,934	+36%	+$220K	0.34%	162
2022 Q4	$648K	Sell	16,401 -845	-5%	-$35.3K	0.29%	196
2022 Q3	$693K	Buy	+17,246	New	+$737K	0.32%	175

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jackson Creek Investment Advisors's RPRX Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in Royalty Pharma (RPRX) in Q2 2026: 12,743 shares worth $745K. The stake represents 0.25% of the portfolio and ranks #176 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in RPRX as recently as Q2 2023.

Jackson Creek Investment Advisors first reported a position in RPRX in Q3 2022 and has held it in 5 quarters since. The position peaked at $805K in Q1 2023. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Jackson Creek Investment Advisors held 12,743 shares of Royalty Pharma worth $745K as of Q2 2026.
Royalty Pharma was a new Jackson Creek Investment Advisors position in Q2 2026.
Royalty Pharma made up 0.25% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #176 holding.
Jackson Creek Investment Advisors first reported a position in Royalty Pharma in Q3 2022 and has held it in 5 quarters since.
Jackson Creek Investment Advisors's Royalty Pharma position peaked at $805K in Q1 2023.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.